Prolonged-release buprenorphine formulations: Perspectives for clinical practice
نویسندگان
چکیده
منابع مشابه
Response: Integrating Buprenorphine Therapy Into Clinical Practice
Programs and strategies Van Zee: We are looking to buprenorphine as a possible solution to a very difficult situation. Our clinic is in the heart of Appalachia, in the southwestern corner of Virginia. Until about 3 years ago we had no large-scale opioid addiction, but the OxyContin epidemic changed that. There are now tens of thousands of new opioid addicts in our region. Methadone treatment pr...
متن کاملLithium in Bipolar Disorder: Optimizing Therapy Using Prolonged-Release Formulations
Lithium has been a gold standard in the treatment of bipolar disorder (BD) for several decades. Despite a general reduction in the use of lithium over the past several years, it is effective in the management of both manic and depressive episodes in BD and continues to be recommended as a first-line mood stabilizer. This review provides an overview of the pharmacology of lithium and highlights ...
متن کاملBuprenorphine Formulations: Clinical Best Practice Strategies Recommendations for Perioperative Management of Patients Undergoing Surgical or Interventional Pain Procedures.
BACKGROUND Starting with approval for clinical use in the treatment of opioid dependence in October 2002 by the Food and Drug Administration (FDA), buprenorphine has become an integral treatment option and in recent years, in chronic pain management. Buprenorphine possesses a unique pharmacodynamic and pharmacokinetic profile that can potentially make perioperative analgesia challenging. OBJE...
متن کاملMethodological Issues on a Clinical Trial to Test Tapentadol Prolonged release vs. Oxycodone/Naloxone Prolonged release
To the Editor: A recent article by Baron et al. reports the results of a clinical trial (CT) to compare the effectiveness of tapentadol with oxycodone/ naloxone (Ox/Nal) for the treatment of chronic low back pain of neuropathic origin. This study is a remarkable attempt to progress in this area. We argue, however, that it contains several drawbacks that leave open ground for further trials with...
متن کاملTapentadol Prolonged Release as Used in Clinical Practice in Patients with Severe Chronic Tumor Pain
Objective: This subgroup analysis of a non-interventional study that included general practitioners and internists, assessed efficacy and safety of tapentadol prolonged release (Palexia® retard) as used in routine clinical practice in Germany for the treatment of severe chronic tumor pain. Study design: Data of all patients in the study cohort who were exclusively diagnosed with ‘tumor pain’ (n...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Therapies
سال: 2020
ISSN: 0040-5957
DOI: 10.1016/j.therap.2020.05.007